Table of Contents 1 Secondary Hyperparathyroidism Treatment Market Overview 1.1 Product Overview and Scope of Secondary Hyperparathyroidism Treatment 1.2 Classification of Secondary Hyperparathyroidism Treatment by Types 1.2.1 Global Secondary Hyperparathyroidism Treatment Revenue Comparison by Types (2017-2023) 1.2.2 Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Types in 2017 1.2.3 Surgery 1.2.4 Drugs 1.2.5 Vitamin D 1.2.6 Calcimimetics 1.2.7 Phosphate Binders 1.3 Global Secondary Hyperparathyroidism Treatment Market by Application 1.3.1 Global Secondary Hyperparathyroidism Treatment Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.4 Global Secondary Hyperparathyroidism Treatment Market by Regions 1.4.1 Global Secondary Hyperparathyroidism Treatment Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Secondary Hyperparathyroidism Treatment Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Secondary Hyperparathyroidism Treatment Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Secondary Hyperparathyroidism Treatment Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Secondary Hyperparathyroidism Treatment Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Secondary Hyperparathyroidism Treatment Status and Prospect (2013-2023) 1.5 Global Market Size of Secondary Hyperparathyroidism Treatment (2013-2023) 2 Manufacturers Profiles 2.1 Amgen 2.1.1 Business Overview 2.1.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Amgen Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.2 OPKO Health 2.2.1 Business Overview 2.2.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 OPKO Health Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.3 AbbVie 2.3.1 Business Overview 2.3.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 AbbVie Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.4 Astellas Pharma 2.4.1 Business Overview 2.4.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Astellas Pharma Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.5 Roche 2.5.1 Business Overview 2.5.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Roche Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.6 KAI Pharmaceuticals 2.6.1 Business Overview 2.6.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 KAI Pharmaceuticals Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.7 Kyowa Hakko Kirin 2.7.1 Business Overview 2.7.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Kyowa Hakko Kirin Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.8 Leo Pharma 2.8.1 Business Overview 2.8.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Leo Pharma Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.9 Shire 2.9.1 Business Overview 2.9.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Shire Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.10 Sanofi 2.10.1 Business Overview 2.10.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Sanofi Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.11 Deltanoid Pharmaceuticals 2.11.1 Business Overview 2.11.2 Secondary Hyperparathyroidism Treatment Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Deltanoid Pharmaceuticals Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) 3 Global Secondary Hyperparathyroidism Treatment Market Competition, by Players 3.1 Global Secondary Hyperparathyroidism Treatment Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Secondary Hyperparathyroidism Treatment Players Market Share 3.2.2 Top 10 Secondary Hyperparathyroidism Treatment Players Market Share 3.3 Market Competition Trend 4 Global Secondary Hyperparathyroidism Treatment Market Size by Regions 4.1 Global Secondary Hyperparathyroidism Treatment Revenue and Market Share by Regions 4.2 North America Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 4.3 Europe Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 4.5 South America Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 5 North America Secondary Hyperparathyroidism Treatment Revenue by Countries 5.1 North America Secondary Hyperparathyroidism Treatment Revenue by Countries (2013-2018) 5.2 USA Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 5.3 Canada Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 5.4 Mexico Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 6 Europe Secondary Hyperparathyroidism Treatment Revenue by Countries 6.1 Europe Secondary Hyperparathyroidism Treatment Revenue by Countries (2013-2018) 6.2 Germany Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 6.3 UK Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 6.4 France Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 6.5 Russia Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 6.6 Italy Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue by Countries 7.1 Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue by Countries (2013-2018) 7.2 China Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 7.3 Japan Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 7.4 Korea Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 7.5 India Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 8 South America Secondary Hyperparathyroidism Treatment Revenue by Countries 8.1 South America Secondary Hyperparathyroidism Treatment Revenue by Countries (2013-2018) 8.2 Brazil Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 8.3 Argentina Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 8.4 Colombia Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Secondary Hyperparathyroidism Treatment by Countries 9.1 Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue by Countries (2013-2018) 9.2 Saudi Arabia Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 9.3 UAE Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 9.4 Egypt Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 9.5 Nigeria Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 9.6 South Africa Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) 10 Global Secondary Hyperparathyroidism Treatment Market Segment by Type 10.1 Global Secondary Hyperparathyroidism Treatment Revenue and Market Share by Type (2013-2018) 10.2 Global Secondary Hyperparathyroidism Treatment Market Forecast by Type (2018-2023) 10.3 Surgery Revenue Growth Rate (2013-2023) 10.4 Drugs Revenue Growth Rate (2013-2023) 10.5 Vitamin D Revenue Growth Rate (2013-2023) 10.6 Calcimimetics Revenue Growth Rate (2013-2023) 10.7 Phosphate Binders Revenue Growth Rate (2013-2023) 11 Global Secondary Hyperparathyroidism Treatment Market Segment by Application 11.1 Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Application (2013-2018) 11.2 Secondary Hyperparathyroidism Treatment Market Forecast by Application (2018-2023) 11.3 Hospital Pharmacies Revenue Growth (2013-2018) 11.4 Retail Pharmacies Revenue Growth (2013-2018) 12 Global Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2023) 12.1 Global Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2023) 12.2 Global Secondary Hyperparathyroidism Treatment Market Forecast by Regions (2018-2023) 12.3 North America Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) 12.4 Europe Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) 12.6 South America Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Secondary Hyperparathyroidism Treatment Picture Table Product Specifications of Secondary Hyperparathyroidism Treatment Table Global Secondary Hyperparathyroidism Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Types in 2017 Figure Surgery Picture Figure Drugs Picture Figure Vitamin D Picture Figure Calcimimetics Picture Figure Phosphate Binders Picture Table Global Secondary Hyperparathyroidism Treatment Revenue (Million USD) by Application (2013-2023) Figure Secondary Hyperparathyroidism Treatment Revenue Market Share by Applications in 2017 Figure Hospital Pharmacies Picture Figure Retail Pharmacies Picture Table Global Market Secondary Hyperparathyroidism Treatment Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Secondary Hyperparathyroidism Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Secondary Hyperparathyroidism Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Secondary Hyperparathyroidism Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Secondary Hyperparathyroidism Treatment Revenue (Million USD) and Growth Rate (2013-2023) Table Amgen Basic Information, Manufacturing Base and Competitors Table Amgen Secondary Hyperparathyroidism Treatment Type and Applications Table Amgen Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table OPKO Health Basic Information, Manufacturing Base and Competitors Table OPKO Health Secondary Hyperparathyroidism Treatment Type and Applications Table OPKO Health Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table AbbVie Basic Information, Manufacturing Base and Competitors Table AbbVie Secondary Hyperparathyroidism Treatment Type and Applications Table AbbVie Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Astellas Pharma Basic Information, Manufacturing Base and Competitors Table Astellas Pharma Secondary Hyperparathyroidism Treatment Type and Applications Table Astellas Pharma Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Secondary Hyperparathyroidism Treatment Type and Applications Table Roche Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table KAI Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table KAI Pharmaceuticals Secondary Hyperparathyroidism Treatment Type and Applications Table KAI Pharmaceuticals Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors Table Kyowa Hakko Kirin Secondary Hyperparathyroidism Treatment Type and Applications Table Kyowa Hakko Kirin Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Leo Pharma Basic Information, Manufacturing Base and Competitors Table Leo Pharma Secondary Hyperparathyroidism Treatment Type and Applications Table Leo Pharma Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Shire Basic Information, Manufacturing Base and Competitors Table Shire Secondary Hyperparathyroidism Treatment Type and Applications Table Shire Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Secondary Hyperparathyroidism Treatment Type and Applications Table Sanofi Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Deltanoid Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Deltanoid Pharmaceuticals Secondary Hyperparathyroidism Treatment Type and Applications Table Deltanoid Pharmaceuticals Secondary Hyperparathyroidism Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Global Secondary Hyperparathyroidism Treatment Revenue (Million USD) by Players (2013-2018) Table Global Secondary Hyperparathyroidism Treatment Revenue Share by Players (2013-2018) Figure Global Secondary Hyperparathyroidism Treatment Revenue Share by Players in 2016 Figure Global Secondary Hyperparathyroidism Treatment Revenue Share by Players in 2017 Figure Global Top 5 Players Secondary Hyperparathyroidism Treatment Revenue Market Share in 2017 Figure Global Top 10 Players Secondary Hyperparathyroidism Treatment Revenue Market Share in 2017 Figure Global Secondary Hyperparathyroidism Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Secondary Hyperparathyroidism Treatment Revenue (Million USD) by Regions (2013-2018) Table Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Regions (2013-2018) Figure Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Regions (2013-2018) Figure Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Regions in 2017 Figure North America Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Europe Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure South America Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Table North America Secondary Hyperparathyroidism Treatment Revenue by Countries (2013-2018) Table North America Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries (2013-2018) Figure North America Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries (2013-2018) Figure North America Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries in 2017 Figure USA Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Canada Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Mexico Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Table Europe Secondary Hyperparathyroidism Treatment Revenue (Million USD) by Countries (2013-2018) Figure Europe Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries (2013-2018) Figure Europe Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries in 2017 Figure Germany Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure UK Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure France Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Russia Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Italy Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Table Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries in 2017 Figure China Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Japan Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Korea Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure India Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Southeast Asia Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Table South America Secondary Hyperparathyroidism Treatment Revenue by Countries (2013-2018) Table South America Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries (2013-2018) Figure South America Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries (2013-2018) Figure South America Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries in 2017 Figure Brazil Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Argentina Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Colombia Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Table Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue Market Share by Countries in 2017 Figure Saudi Arabia Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure UAE Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Egypt Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure Nigeria Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Figure South Africa Secondary Hyperparathyroidism Treatment Revenue and Growth Rate (2013-2018) Table Global Secondary Hyperparathyroidism Treatment Revenue (Million USD) by Type (2013-2018) Table Global Secondary Hyperparathyroidism Treatment Revenue Share by Type (2013-2018) Figure Global Secondary Hyperparathyroidism Treatment Revenue Share by Type (2013-2018) Figure Global Secondary Hyperparathyroidism Treatment Revenue Share by Type in 2017 Table Global Secondary Hyperparathyroidism Treatment Revenue Forecast by Type (2018-2023) Figure Global Secondary Hyperparathyroidism Treatment Market Share Forecast by Type (2018-2023) Figure Global Surgery Revenue Growth Rate (2013-2018) Figure Global Drugs Revenue Growth Rate (2013-2018) Figure Global Vitamin D Revenue Growth Rate (2013-2018) Figure Global Calcimimetics Revenue Growth Rate (2013-2018) Figure Global Phosphate Binders Revenue Growth Rate (2013-2018) Table Global Secondary Hyperparathyroidism Treatment Revenue by Application (2013-2018) Table Global Secondary Hyperparathyroidism Treatment Revenue Share by Application (2013-2018) Figure Global Secondary Hyperparathyroidism Treatment Revenue Share by Application (2013-2018) Figure Global Secondary Hyperparathyroidism Treatment Revenue Share by Application in 2017 Table Global Secondary Hyperparathyroidism Treatment Revenue Forecast by Application (2018-2023) Figure Global Secondary Hyperparathyroidism Treatment Market Share Forecast by Application (2018-2023) Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018) Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018) Figure Global Secondary Hyperparathyroidism Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Secondary Hyperparathyroidism Treatment Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Secondary Hyperparathyroidism Treatment Revenue Market Share Forecast by Regions (2018-2023) Figure North America Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) Figure Europe Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) Figure Asia-Pacific Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) Figure South America Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023) Figure Middle East and Africa Secondary Hyperparathyroidism Treatment Revenue Market Forecast (2018-2023)

Amgen OPKO Health AbbVie Astellas Pharma Roche KAI Pharmaceuticals Kyowa Hakko Kirin Leo Pharma Shire Sanofi Deltanoid Pharmaceuticals